High Mark Wealth Management LLC Halozyme Therapeutics, Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 30 shares of HALO stock, worth $1,915. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$1,915
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HALO
# of Institutions
549Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.12 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$848 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$459 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$266 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$220 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.89B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...